切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2021, Vol. 18 ›› Issue (02) : 143 -149. doi: 10.3877/cma.j.issn.1672-6448.2021.02.004

所属专题: 乳腺超声 文献

心血管超声影像学

斑点追踪技术监测低剂量蒽环类药物对乳腺癌新辅助化疗患者的心脏毒性
谭雪莹1, 张晶1, 任卫东1,(), 张昕彤1, 杨洋2   
  1. 1. 110004 沈阳,中国医科大学附属盛京医院超声科
    2. 161000 齐齐哈尔市结核病防治院
  • 收稿日期:2020-05-13 出版日期:2021-02-01
  • 通信作者: 任卫东
  • 基金资助:
    国家自然科学基金项目(81571686)

Dynamic evaluation of cardiotoxicity of low dose anthracycline in breast cancer patients during neoadjuvant chemotherapy using two-dimensional speckle tracking imaging

Xueying Tan1, Jing Zhang1, Weidong Ren1,(), Xintong Zhang1, yang Yang2   

  1. 1. Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang 110004, China
    2. Qiqihar Tuberculosis Control Institute, Qiqihar 161000, China
  • Received:2020-05-13 Published:2021-02-01
  • Corresponding author: Weidong Ren
引用本文:

谭雪莹, 张晶, 任卫东, 张昕彤, 杨洋. 斑点追踪技术监测低剂量蒽环类药物对乳腺癌新辅助化疗患者的心脏毒性[J/OL]. 中华医学超声杂志(电子版), 2021, 18(02): 143-149.

Xueying Tan, Jing Zhang, Weidong Ren, Xintong Zhang, yang Yang. Dynamic evaluation of cardiotoxicity of low dose anthracycline in breast cancer patients during neoadjuvant chemotherapy using two-dimensional speckle tracking imaging[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2021, 18(02): 143-149.

目的

应用二维斑点追踪成像(2D-STI)技术评价接受低剂量蒽环类药物治疗的乳腺癌新辅助化疗患者的左心室收缩功能。

方法

选取2018年12月至2020年3月在中国医科大学附属盛京医院应用低剂量蒽环类药物行新辅助化疗的乳腺癌患者49例为化疗组,选取25例与化疗组相匹配的健康志愿者作为对照组。在每次化疗前(t0~t5)、最终手术前(t6)行超声心动图检查,获得常规超声心动图参数。应用Qlab软件对图像进行追踪分析,获得整体纵向应变(GLS)、整体径向应变(GRS)、整体圆周应变(GCS);心尖扭转角度峰值(AP-Prot)、心底扭转角度峰值(MV-Prot)、左心室整体扭转角度峰值(LV-Tw)。对化疗组化疗前(t0)与对照组各参数、化疗组不同时间点(t0~t6)各参数的差异进行分析比较。

结果

化疗组在化疗前(t0)与对照组左心室各参数比较无明显差异;常规超声心动图参数E/A、左心室射血分数、E/e'在化疗期间较晚发生减低,其中LVEF在t4出现减低,在t0~t6分别为62.4%±2.0%、62.4%±2.0%、62.3%±2.1%、62.0%±2.0%、61.6%±1.8%、61.1%±1.7%、60.2%±1.8%(F=13.533,P<0.05),t4与t0及t3两两比较的平均值差值分别为0.857和0.548(均P<0.05)。应变参数GLS、GCS、GRS呈下降趋势,GLS最早在t1开始降低,在t0~t6分别为-22.0%±1.4%、-21.8%±1.4%、-21.1%±1.4%、-20.0%±1.0%、-19.3%±1.1%、-18.7%±1.2%、-18.1%±1.2%(F=62.473,P<0.05),t1与t0比较的平均值差值为0.224(P<0.05);扭转参数MV-Prot的绝对值在t0~t6无明显变化(P>0.05),AP-Prot和LV-Tw的绝对值均在t1出现降低,以AP-Prot最明显(t1 vs t0:P<0.05)。

结论

2D-STI监测新辅助化疗期间低剂量蒽环类药物导致的心脏毒性具有重要价值,GLS和AP-Prot是最敏感的指标。

Objective

To investigate the value of two-dimensional speckle tracking imaginein detecting the myocardial dysfunction of the left ventriclein patients with breast cancer during neoadjuvant chemotherapy with anthracyclines (ANT).

Methods

A total of 49 female patients who received ANT treatment (ANT group) at Shengjing Hospital of China Medical University from December 2018 to March 2020 and 25 healthy volunteers (control group) were collected. Echocardiography was performed before every episode of chemotherapy (t0-t5) and before surgery (t6) to obtain routine echocardiographic parameters. Speckle tracking software was used to analyze the general parameters, including global longitudinal strain (GLS), global radial strain (GRS), global circumferential strain (GCS), apical peak rotation (AP-Prot), mitral valvular peak rotation (MV-Prot), and left ventricular twist (LV-Tw). Parameters were compared among different timepoints and between the two groups.

Results

There was no significant difference in left ventricular parameters between the ANT group (t0) and the control group. The general echocardiography parameters E/A, left ventricular ejection fraction (LVEF), and E/e' decreased, among which LVEF decreased significantly at t4. LVEF values were 62.4%±2.0%, 62.4%±2.0%, 62.3%±2.1%, 62.0%±2.0%, 61.6%±1.8%, 61.1%±1.7%, and 60.2%±1.8% at t0 to t6,respectively (F=13.533, P<0.05), and the mean difference between t4 and t0 and between t4 and t3 was 0.857 and 0.548, respectively (P<0.05 for both). The strain parameters including GLS, GCS, and GRS showed a downward trend. GLS began to decrease at t1, and it was -22.0%±1.4%, -21.8%±1.4%, -21.1%±1.4%, -20.0%±1.0%, -19.3%±1.1%, -18.7%±1.2%, and -18.1%±1.2%at t0 to t6,respectively (F=62.473, P<0.05), and the mean difference between t1 and t0 was 0.224 (P<0.05). The absolute value of torsion parameter MV-prot did not change significantly. The absolute values of AP-prot and LV-TW decreased at t1. AP-prot decreased most obviously (t1 vs t0: P<0.05).

Conclusion

Speckle tracking imaging is of great value in monitoring the cardiotoxicity caused by low dose ANT during neoadjuvant chemotherapy. GLS and AP-Protarethe most sensitive indicators to evaluate the cardiac injury in breast cancer patients receiving low dose ANT.

表1 对照组与化疗组一般资料比较 [
xˉ
±s或例(%)]
表2 化疗组与对照组常规超声心动图参数比较(
xˉ
±s
表3 化疗组与对照组左心室应变参数比较(%,
xˉ
±s
表4 化疗组与对照组左心室旋转/扭转参数比较(
xˉ
±s
图1 同一乳腺癌患者在新辅助化疗期间不同时间点心尖扭转角度峰值的变化。图a为化疗前;图b 为第1 次化疗后;图c为第2 次化疗后;图d为第3 次化疗后;图e为第4 次化疗后;图f 为第5 次化疗后;图g 为手术前
1
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials[J]. Lancet Oncol, 2018, 19(1): 27-39.
2
Dalla K, Bech-Hanssen O, Oras J, et al. Speckle tracking-vs conventional echocardiography for the detection of myocardial injury-A study on patients with subarachnoid haemorrhage[J]. Acta Anaesthesiol Scand, 2019, 63(3): 365-372.
3
Seidman A, Hudis C, Pierri MK, et al. Cardiac dysfunction in the trastuzumab clinical trials experience[J]. J Clin Oncol, 2002, 20(5): 1215-1221.
4
Piper S, McDonagh T. Heart failure and chemotherapeutic agents[J]. Future Cardiol, 2015, 11(4): 453-470.
5
Lee CH, Zhang JF, Yuan KS, et al. Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer[J]. Strahlenther Onkol, 2019, 195(7): 629-639.
6
Armenian S, Bhatia S. Predicting and preventing anthracycline-related cardiotoxicity[J]. Am Soc Clin Oncol Educ Book, 2018, 38: 3-12.
7
Wolf CM, Reiner B, Kühn A, et al. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging[J]. Front Pediatr, 2020, 8: 123.
8
Dogru A, Cabuk D, Sahin T, et al. Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines[J]. Onkologie, 2013, 36(12): 712-716.
9
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志, 2019, 29(8): 609-679.
10
蔡璐, 尹立雪, 王斯佳, 等. 超声分层应变成像技术对阿霉素致大鼠急性左心室心肌早期毒性损伤的评价[J/CD]. 中华医学超声杂志(电子版), 2019, 16(5): 386-392.
11
Anqi Y, Yu Z, Mingjun X, et al. Use of echocardiography to monitor myocardial damage during anthracycline chemotherapy[J]. Echocardiography, 2019, 36(3): 495-502.
12
Arciniegas Calle MC, Sandhu NP, Xia H, et al. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer[J]. BMC Cancer, 2018, 18(1): 1037.
13
Torrent-Guasp F, Kocica MJ, Corno AF, et al. Towards new understanding of the heart structure and function[J]. Eur J Cardiothorac Surg, 2005, 27(2): 191-201.
14
陈以慈. 心脏供血的解剖学[J]. 新医学, 1990, (3): 115-116.
15
Mornoş C, Petrescu L. Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist[J]. Can J Physiol Pharmacol, 2013, 91(8):601-607.
16
梁梦婕, 金怡, 郑哲岚. 超声二维斑点追踪技术在蒽环类化疗药物心脏毒性监测中的应用价值[J/CD]. 中华医学超声杂志(电子版), 2019, 16(10): 749-755.
17
O'Halloran N, Lowery A, Curran C, et al. A review of the impact of neoadjuvant chemotherapy on breast surgery practice and outcomes[J]. Clin Breast Cancer, 2019, 19(5): 377-382.
18
Huang J, Yan ZN, Rui YF, et al. Longitudinal rotation: a new way to detect the cardiotoxicity of anthracycline-based chemotherapy in breast cancer patients[J]. Oncotarget, 2017, 8(41): 70072-70083.
19
Hjertaas JJ, Matre K. A left ventricular phantom for 3D echocardiographic twist measurements[J]. Biomed Tech (Berl), 2020, 65(2): 209-218.
[1] 杜祖升, 赵博文, 张帧, 潘美, 彭晓慧, 陈冉, 毛彦恺. 应用二维斑点追踪成像技术评估孕周及心尖方向对中晚孕期正常胎儿左心房应变的影响[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 843-851.
[2] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[3] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[4] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[5] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[6] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[7] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[8] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[9] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
阅读次数
全文


摘要